The integration of artificial intelligence (AI) and cancer genomics has transformed precision oncology, enabling early detection and personalized treatment strategies. AI techniques, including machine learning and deep learning, analyze complex genomic data to uncover mutations and identify biomarkers. These approaches enhance early cancer detection through tools like liquid biopsies and optimize personalized treatments by predicting drug responses and refining immunotherapy. Despite significant advancements, challenges such as data privacy, model interpretability, and clinical integration remain. Future efforts focus on interdisciplinary collaboration, explainable AI, and federated learning to overcome these hurdles and further revolutionize cancer care